| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning regulation. | |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||
3 | represented in the General Assembly: | |||||||||||||||||||
4 | Section 5. The Pharmacy Practice Act is amended by | |||||||||||||||||||
5 | changing Section 3 as follows: | |||||||||||||||||||
6 | (225 ILCS 85/3) | |||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2028) | |||||||||||||||||||
8 | Sec. 3. Definitions. For the purpose of this Act, except | |||||||||||||||||||
9 | where otherwise limited therein: | |||||||||||||||||||
10 | (a) "Pharmacy" or "drugstore" means and includes every | |||||||||||||||||||
11 | store, shop, pharmacy department, or other place where | |||||||||||||||||||
12 | pharmacist care is provided by a pharmacist (1) where drugs, | |||||||||||||||||||
13 | medicines, or poisons are dispensed, sold or offered for sale | |||||||||||||||||||
14 | at retail, or displayed for sale at retail; or (2) where | |||||||||||||||||||
15 | prescriptions of physicians, dentists, advanced practice | |||||||||||||||||||
16 | registered nurses, physician assistants, veterinarians, | |||||||||||||||||||
17 | podiatric physicians, or optometrists, within the limits of | |||||||||||||||||||
18 | their licenses, are compounded, filled, or dispensed; or (3) | |||||||||||||||||||
19 | which has upon it or displayed within it, or affixed to or used | |||||||||||||||||||
20 | in connection with it, a sign bearing the word or words | |||||||||||||||||||
21 | "Pharmacist", "Druggist", "Pharmacy", "Pharmaceutical Care", | |||||||||||||||||||
22 | "Apothecary", "Drugstore", "Medicine Store", "Prescriptions", | |||||||||||||||||||
23 | "Drugs", "Dispensary", "Medicines", or any word or words of |
| |||||||
| |||||||
1 | similar or like import, either in the English language or any | ||||||
2 | other language; or (4) where the characteristic prescription | ||||||
3 | sign (Rx) or similar design is exhibited; or (5) any store, or | ||||||
4 | shop, or other place with respect to which any of the above | ||||||
5 | words, objects, signs or designs are used in any | ||||||
6 | advertisement. | ||||||
7 | (b) "Drugs" means and includes (1) articles recognized in | ||||||
8 | the official United States Pharmacopoeia/National Formulary | ||||||
9 | (USP/NF), or any supplement thereto and being intended for and | ||||||
10 | having for their main use the diagnosis, cure, mitigation, | ||||||
11 | treatment or prevention of disease in man or other animals, as | ||||||
12 | approved by the United States Food and Drug Administration, | ||||||
13 | but does not include devices or their components, parts, or | ||||||
14 | accessories; and (2) all other articles intended for and | ||||||
15 | having for their main use the diagnosis, cure, mitigation, | ||||||
16 | treatment or prevention of disease in man or other animals, as | ||||||
17 | approved by the United States Food and Drug Administration, | ||||||
18 | but does not include devices or their components, parts, or | ||||||
19 | accessories; and (3) articles (other than food) having for | ||||||
20 | their main use and intended to affect the structure or any | ||||||
21 | function of the body of man or other animals; and (4) articles | ||||||
22 | having for their main use and intended for use as a component | ||||||
23 | or any articles specified in clause (1), (2) or (3); but does | ||||||
24 | not include devices or their components, parts or accessories. | ||||||
25 | (c) "Medicines" means and includes all drugs intended for | ||||||
26 | human or veterinary use approved by the United States Food and |
| |||||||
| |||||||
1 | Drug Administration. | ||||||
2 | (d) "Practice of pharmacy" means: | ||||||
3 | (1) the interpretation and the provision of assistance | ||||||
4 | in the monitoring, evaluation, and implementation of | ||||||
5 | prescription drug orders; | ||||||
6 | (2) the dispensing of prescription drug orders; | ||||||
7 | (3) participation in drug and device selection; | ||||||
8 | (4) drug administration limited to the administration | ||||||
9 | of oral, topical, injectable, and inhalation as follows: | ||||||
10 | (A) in the context of patient education on the | ||||||
11 | proper use or delivery of medications; | ||||||
12 | (B) vaccination of patients 7 years of age and | ||||||
13 | older pursuant to a valid prescription or standing | ||||||
14 | order, by a physician licensed to practice medicine in | ||||||
15 | all its branches, except for vaccinations covered by | ||||||
16 | paragraph (15), upon completion of appropriate | ||||||
17 | training, including how to address contraindications | ||||||
18 | and adverse reactions set forth by rule, with | ||||||
19 | notification to the patient's physician and | ||||||
20 | appropriate record retention, or pursuant to hospital | ||||||
21 | pharmacy and therapeutics committee policies and | ||||||
22 | procedures. Eligible vaccines are those listed on the | ||||||
23 | U.S. Centers for Disease Control and Prevention (CDC) | ||||||
24 | Recommended Immunization Schedule, the CDC's Health | ||||||
25 | Information for International Travel, or the U.S. Food | ||||||
26 | and Drug Administration's Vaccines Licensed and |
| |||||||
| |||||||
1 | Authorized for Use in the United States. As applicable | ||||||
2 | to the State's Medicaid program and other payers, | ||||||
3 | vaccines ordered and administered in accordance with | ||||||
4 | this subsection shall be covered and reimbursed at no | ||||||
5 | less than the rate that the vaccine is reimbursed when | ||||||
6 | ordered and administered by a physician; | ||||||
7 | (B-5) (blank); following the initial | ||||||
8 | administration of long-acting or extended-release form | ||||||
9 | opioid antagonists by a physician licensed to practice | ||||||
10 | medicine in all its branches, administration of | ||||||
11 | injections of long-acting or extended-release form | ||||||
12 | opioid antagonists for the treatment of substance use | ||||||
13 | disorder, pursuant to a valid prescription by a | ||||||
14 | physician licensed to practice medicine in all its | ||||||
15 | branches, upon completion of appropriate training, | ||||||
16 | including how to address contraindications and adverse | ||||||
17 | reactions, including, but not limited to, respiratory | ||||||
18 | depression and the performance of cardiopulmonary | ||||||
19 | resuscitation, set forth by rule, with notification to | ||||||
20 | the patient's physician and appropriate record | ||||||
21 | retention, or pursuant to hospital pharmacy and | ||||||
22 | therapeutics committee policies and procedures; | ||||||
23 | (C) administration of injections of | ||||||
24 | alpha-hydroxyprogesterone caproate, pursuant to a | ||||||
25 | valid prescription, by a physician licensed to | ||||||
26 | practice medicine in all its branches, upon completion |
| |||||||
| |||||||
1 | of appropriate training, including how to address | ||||||
2 | contraindications and adverse reactions set forth by | ||||||
3 | rule, with notification to the patient's physician and | ||||||
4 | appropriate record retention, or pursuant to hospital | ||||||
5 | pharmacy and therapeutics committee policies and | ||||||
6 | procedures; and | ||||||
7 | (D) administration of long-acting injectables for | ||||||
8 | mental health or substance use disorders injections of | ||||||
9 | long-term antipsychotic medications pursuant to a | ||||||
10 | valid prescription by a physician licensed to practice | ||||||
11 | medicine in all its branches, upon completion of | ||||||
12 | appropriate training conducted by an Accreditation | ||||||
13 | Council of Pharmaceutical Education accredited | ||||||
14 | provider, including how to address contraindications | ||||||
15 | and adverse reactions set forth by rule, with | ||||||
16 | notification to the patient's physician and | ||||||
17 | appropriate record retention, or pursuant to hospital | ||||||
18 | pharmacy and therapeutics committee policies and | ||||||
19 | procedures. | ||||||
20 | (5) (blank); | ||||||
21 | (6) drug regimen review; | ||||||
22 | (7) drug or drug-related research; | ||||||
23 | (8) the provision of patient counseling; | ||||||
24 | (9) the practice of telepharmacy; | ||||||
25 | (10) the provision of those acts or services necessary | ||||||
26 | to provide pharmacist care; |
| |||||||
| |||||||
1 | (11) medication therapy management; | ||||||
2 | (12) the responsibility for compounding and labeling | ||||||
3 | of drugs and devices (except labeling by a manufacturer, | ||||||
4 | repackager, or distributor of non-prescription drugs and | ||||||
5 | commercially packaged legend drugs and devices), proper | ||||||
6 | and safe storage of drugs and devices, and maintenance of | ||||||
7 | required records; | ||||||
8 | (13) the assessment and consultation of patients and | ||||||
9 | dispensing of hormonal contraceptives; | ||||||
10 | (14) the initiation, dispensing, or administration of | ||||||
11 | drugs, laboratory tests, assessments, referrals, and | ||||||
12 | consultations for human immunodeficiency virus | ||||||
13 | pre-exposure prophylaxis and human immunodeficiency virus | ||||||
14 | post-exposure prophylaxis under Section 43.5; | ||||||
15 | (15) vaccination of patients 7 years of age and older | ||||||
16 | for COVID-19 or influenza subcutaneously, intramuscularly, | ||||||
17 | or orally as authorized, approved, or licensed by the | ||||||
18 | United States Food and Drug Administration, pursuant to | ||||||
19 | the following conditions: | ||||||
20 | (A) the vaccine must be authorized or licensed by | ||||||
21 | the United States Food and Drug Administration; | ||||||
22 | (B) the vaccine must be ordered and administered | ||||||
23 | according to the Advisory Committee on Immunization | ||||||
24 | Practices standard immunization schedule; | ||||||
25 | (C) the pharmacist must complete a course of | ||||||
26 | training accredited by the Accreditation Council on |
| |||||||
| |||||||
1 | Pharmacy Education or a similar health authority or | ||||||
2 | professional body approved by the Division of | ||||||
3 | Professional Regulation; | ||||||
4 | (D) the pharmacist must have a current certificate | ||||||
5 | in basic cardiopulmonary resuscitation; | ||||||
6 | (E) the pharmacist must complete, during each | ||||||
7 | State licensing period, a minimum of 2 hours of | ||||||
8 | immunization-related continuing pharmacy education | ||||||
9 | approved by the Accreditation Council on Pharmacy | ||||||
10 | Education; | ||||||
11 | (F) the pharmacist must comply with recordkeeping | ||||||
12 | and reporting requirements of the jurisdiction in | ||||||
13 | which the pharmacist administers vaccines, including | ||||||
14 | informing the patient's primary-care provider, when | ||||||
15 | available, and complying with requirements whereby the | ||||||
16 | person administering a vaccine must review the vaccine | ||||||
17 | registry or other vaccination records prior to | ||||||
18 | administering the vaccine; and | ||||||
19 | (G) the pharmacist must inform the pharmacist's | ||||||
20 | patients who are less than 18 years old, as well as the | ||||||
21 | adult caregiver accompanying the child, of the | ||||||
22 | importance of a well-child visit with a pediatrician | ||||||
23 | or other licensed primary-care provider and must refer | ||||||
24 | patients as appropriate; | ||||||
25 | (16) the ordering and administration of COVID-19 | ||||||
26 | therapeutics subcutaneously, intramuscularly, or orally |
| |||||||
| |||||||
1 | with notification to the patient's physician and | ||||||
2 | appropriate record retention or pursuant to hospital | ||||||
3 | pharmacy and therapeutics committee policies and | ||||||
4 | procedures. Eligible therapeutics are those approved, | ||||||
5 | authorized, or licensed by the United States Food and Drug | ||||||
6 | Administration and must be administered subcutaneously, | ||||||
7 | intramuscularly, or orally in accordance with that | ||||||
8 | approval, authorization, or licensing; and | ||||||
9 | (17) the ordering and administration of tests and | ||||||
10 | screenings for (i) influenza, (ii) SARS-COV 2, and (iii) | ||||||
11 | health conditions identified by a statewide public health | ||||||
12 | emergency, as defined in the Illinois Emergency Management | ||||||
13 | Agency Act, with notification to the patient's physician | ||||||
14 | and appropriate record retention or pursuant to hospital | ||||||
15 | pharmacy and therapeutics committee policies and | ||||||
16 | procedures. Eligible tests and screenings are those | ||||||
17 | approved, authorized, or licensed by the United States | ||||||
18 | Food and Drug Administration and must be administered in | ||||||
19 | accordance with that approval, authorization, or | ||||||
20 | licensing. | ||||||
21 | A pharmacist who orders or administers tests or | ||||||
22 | screenings for health conditions described in this | ||||||
23 | paragraph may use a test that may guide clinical | ||||||
24 | decision-making for the health condition that is waived | ||||||
25 | under the federal Clinical Laboratory Improvement | ||||||
26 | Amendments of 1988 and regulations promulgated thereunder |
| |||||||
| |||||||
1 | or any established screening procedure that is established | ||||||
2 | under a statewide protocol. | ||||||
3 | A pharmacist may delegate the administrative and | ||||||
4 | technical tasks of performing a test for the health | ||||||
5 | conditions described in this paragraph to a registered | ||||||
6 | pharmacy technician or student pharmacist acting under the | ||||||
7 | supervision of the pharmacist. | ||||||
8 | A pharmacist who performs any of the acts defined as the | ||||||
9 | practice of pharmacy in this State must be actively licensed | ||||||
10 | as a pharmacist under this Act. | ||||||
11 | (e) "Prescription" means and includes any written, oral, | ||||||
12 | facsimile, or electronically transmitted order for drugs or | ||||||
13 | medical devices, issued by a physician licensed to practice | ||||||
14 | medicine in all its branches, dentist, veterinarian, podiatric | ||||||
15 | physician, or optometrist, within the limits of his or her | ||||||
16 | license, by a physician assistant in accordance with | ||||||
17 | subsection (f) of Section 4, or by an advanced practice | ||||||
18 | registered nurse in accordance with subsection (g) of Section | ||||||
19 | 4, containing the following: (1) name of the patient; (2) date | ||||||
20 | when prescription was issued; (3) name and strength of drug or | ||||||
21 | description of the medical device prescribed; and (4) | ||||||
22 | quantity; (5) directions for use; (6) prescriber's name, | ||||||
23 | address, and signature; and (7) DEA registration number where | ||||||
24 | required, for controlled substances. The prescription may, but | ||||||
25 | is not required to, list the illness, disease, or condition | ||||||
26 | for which the drug or device is being prescribed. DEA |
| |||||||
| |||||||
1 | registration numbers shall not be required on inpatient drug | ||||||
2 | orders. A prescription for medication other than controlled | ||||||
3 | substances shall be valid for up to 15 months from the date | ||||||
4 | issued for the purpose of refills, unless the prescription | ||||||
5 | states otherwise. | ||||||
6 | (f) "Person" means and includes a natural person, | ||||||
7 | partnership, association, corporation, government entity, or | ||||||
8 | any other legal entity. | ||||||
9 | (g) "Department" means the Department of Financial and | ||||||
10 | Professional Regulation. | ||||||
11 | (h) "Board of Pharmacy" or "Board" means the State Board | ||||||
12 | of Pharmacy of the Department of Financial and Professional | ||||||
13 | Regulation. | ||||||
14 | (i) "Secretary" means the Secretary of Financial and | ||||||
15 | Professional Regulation. | ||||||
16 | (j) "Drug product selection" means the interchange for a | ||||||
17 | prescribed pharmaceutical product in accordance with Section | ||||||
18 | 25 of this Act and Section 3.14 of the Illinois Food, Drug and | ||||||
19 | Cosmetic Act. | ||||||
20 | (k) "Inpatient drug order" means an order issued by an | ||||||
21 | authorized prescriber for a resident or patient of a facility | ||||||
22 | licensed under the Nursing Home Care Act, the ID/DD Community | ||||||
23 | Care Act, the MC/DD Act, the Specialized Mental Health | ||||||
24 | Rehabilitation Act of 2013, the Hospital Licensing Act, or the | ||||||
25 | University of Illinois Hospital Act, or a facility which is | ||||||
26 | operated by the Department of Human Services (as successor to |
| |||||||
| |||||||
1 | the Department of Mental Health and Developmental | ||||||
2 | Disabilities) or the Department of Corrections. | ||||||
3 | (k-5) "Pharmacist" means an individual health care | ||||||
4 | professional and provider currently licensed by this State to | ||||||
5 | engage in the practice of pharmacy. | ||||||
6 | (l) "Pharmacist in charge" means the licensed pharmacist | ||||||
7 | whose name appears on a pharmacy license and who is | ||||||
8 | responsible for all aspects of the operation related to the | ||||||
9 | practice of pharmacy. | ||||||
10 | (m) "Dispense" or "dispensing" means the interpretation, | ||||||
11 | evaluation, and implementation of a prescription drug order, | ||||||
12 | including the preparation and delivery of a drug or device to a | ||||||
13 | patient or patient's agent in a suitable container | ||||||
14 | appropriately labeled for subsequent administration to or use | ||||||
15 | by a patient in accordance with applicable State and federal | ||||||
16 | laws and regulations. "Dispense" or "dispensing" does not mean | ||||||
17 | the physical delivery to a patient or a patient's | ||||||
18 | representative in a home or institution by a designee of a | ||||||
19 | pharmacist or by common carrier. "Dispense" or "dispensing" | ||||||
20 | also does not mean the physical delivery of a drug or medical | ||||||
21 | device to a patient or patient's representative by a | ||||||
22 | pharmacist's designee within a pharmacy or drugstore while the | ||||||
23 | pharmacist is on duty and the pharmacy is open. | ||||||
24 | (n) "Nonresident pharmacy" means a pharmacy that is | ||||||
25 | located in a state, commonwealth, or territory of the United | ||||||
26 | States, other than Illinois, that delivers, dispenses, or |
| |||||||
| |||||||
1 | distributes, through the United States Postal Service, | ||||||
2 | commercially acceptable parcel delivery service, or other | ||||||
3 | common carrier, to Illinois residents, any substance which | ||||||
4 | requires a prescription. | ||||||
5 | (o) "Compounding" means the preparation and mixing of | ||||||
6 | components, excluding flavorings, (1) as the result of a | ||||||
7 | prescriber's prescription drug order or initiative based on | ||||||
8 | the prescriber-patient-pharmacist relationship in the course | ||||||
9 | of professional practice or (2) for the purpose of, or | ||||||
10 | incident to, research, teaching, or chemical analysis and not | ||||||
11 | for sale or dispensing. "Compounding" includes the preparation | ||||||
12 | of drugs or devices in anticipation of receiving prescription | ||||||
13 | drug orders based on routine, regularly observed dispensing | ||||||
14 | patterns. Commercially available products may be compounded | ||||||
15 | for dispensing to individual patients only if all of the | ||||||
16 | following conditions are met: (i) the commercial product is | ||||||
17 | not reasonably available from normal distribution channels in | ||||||
18 | a timely manner to meet the patient's needs and (ii) the | ||||||
19 | prescribing practitioner has requested that the drug be | ||||||
20 | compounded. | ||||||
21 | (p) (Blank). | ||||||
22 | (q) (Blank). | ||||||
23 | (r) "Patient counseling" means the communication between a | ||||||
24 | pharmacist or a student pharmacist under the supervision of a | ||||||
25 | pharmacist and a patient or the patient's representative about | ||||||
26 | the patient's medication or device for the purpose of |
| |||||||
| |||||||
1 | optimizing proper use of prescription medications or devices. | ||||||
2 | "Patient counseling" may include without limitation (1) | ||||||
3 | obtaining a medication history; (2) acquiring a patient's | ||||||
4 | allergies and health conditions; (3) facilitation of the | ||||||
5 | patient's understanding of the intended use of the medication; | ||||||
6 | (4) proper directions for use; (5) significant potential | ||||||
7 | adverse events; (6) potential food-drug interactions; and (7) | ||||||
8 | the need to be compliant with the medication therapy. A | ||||||
9 | pharmacy technician may only participate in the following | ||||||
10 | aspects of patient counseling under the supervision of a | ||||||
11 | pharmacist: (1) obtaining medication history; (2) providing | ||||||
12 | the offer for counseling by a pharmacist or student | ||||||
13 | pharmacist; and (3) acquiring a patient's allergies and health | ||||||
14 | conditions. | ||||||
15 | (s) "Patient profiles" or "patient drug therapy record" | ||||||
16 | means the obtaining, recording, and maintenance of patient | ||||||
17 | prescription information, including prescriptions for | ||||||
18 | controlled substances, and personal information. | ||||||
19 | (t) (Blank). | ||||||
20 | (u) "Medical device" or "device" means an instrument, | ||||||
21 | apparatus, implement, machine, contrivance, implant, in vitro | ||||||
22 | reagent, or other similar or related article, including any | ||||||
23 | component part or accessory, required under federal law to | ||||||
24 | bear the label "Caution: Federal law requires dispensing by or | ||||||
25 | on the order of a physician". A seller of goods and services | ||||||
26 | who, only for the purpose of retail sales, compounds, sells, |
| |||||||
| |||||||
1 | rents, or leases medical devices shall not, by reasons | ||||||
2 | thereof, be required to be a licensed pharmacy. | ||||||
3 | (v) "Unique identifier" means an electronic signature, | ||||||
4 | handwritten signature or initials, thumb print, or other | ||||||
5 | acceptable biometric or electronic identification process as | ||||||
6 | approved by the Department. | ||||||
7 | (w) "Current usual and customary retail price" means the | ||||||
8 | price that a pharmacy charges to a non-third-party payor. | ||||||
9 | (x) "Automated pharmacy system" means a mechanical system | ||||||
10 | located within the confines of the pharmacy or remote location | ||||||
11 | that performs operations or activities, other than compounding | ||||||
12 | or administration, relative to storage, packaging, dispensing, | ||||||
13 | or distribution of medication, and which collects, controls, | ||||||
14 | and maintains all transaction information. | ||||||
15 | (y) "Drug regimen review" means and includes the | ||||||
16 | evaluation of prescription drug orders and patient records for | ||||||
17 | (1) known allergies; (2) drug or potential therapy | ||||||
18 | contraindications; (3) reasonable dose, duration of use, and | ||||||
19 | route of administration, taking into consideration factors | ||||||
20 | such as age, gender, and contraindications; (4) reasonable | ||||||
21 | directions for use; (5) potential or actual adverse drug | ||||||
22 | reactions; (6) drug-drug interactions; (7) drug-food | ||||||
23 | interactions; (8) drug-disease contraindications; (9) | ||||||
24 | therapeutic duplication; (10) patient laboratory values when | ||||||
25 | authorized and available; (11) proper utilization (including | ||||||
26 | over or under utilization) and optimum therapeutic outcomes; |
| |||||||
| |||||||
1 | and (12) abuse and misuse. | ||||||
2 | (z) "Electronically transmitted prescription" means a | ||||||
3 | prescription that is created, recorded, or stored by | ||||||
4 | electronic means; issued and validated with an electronic | ||||||
5 | signature; and transmitted by electronic means directly from | ||||||
6 | the prescriber to a pharmacy. An electronic prescription is | ||||||
7 | not an image of a physical prescription that is transferred by | ||||||
8 | electronic means from computer to computer, facsimile to | ||||||
9 | facsimile, or facsimile to computer. | ||||||
10 | (aa) "Medication therapy management services" means a | ||||||
11 | distinct service or group of services offered by licensed | ||||||
12 | pharmacists, physicians licensed to practice medicine in all | ||||||
13 | its branches, advanced practice registered nurses authorized | ||||||
14 | in a written agreement with a physician licensed to practice | ||||||
15 | medicine in all its branches, or physician assistants | ||||||
16 | authorized in guidelines by a supervising physician that | ||||||
17 | optimize therapeutic outcomes for individual patients through | ||||||
18 | improved medication use. In a retail or other non-hospital | ||||||
19 | pharmacy, medication therapy management services shall consist | ||||||
20 | of the evaluation of prescription drug orders and patient | ||||||
21 | medication records to resolve conflicts with the following: | ||||||
22 | (1) known allergies; | ||||||
23 | (2) drug or potential therapy contraindications; | ||||||
24 | (3) reasonable dose, duration of use, and route of | ||||||
25 | administration, taking into consideration factors such as | ||||||
26 | age, gender, and contraindications; |
| |||||||
| |||||||
1 | (4) reasonable directions for use; | ||||||
2 | (5) potential or actual adverse drug reactions; | ||||||
3 | (6) drug-drug interactions; | ||||||
4 | (7) drug-food interactions; | ||||||
5 | (8) drug-disease contraindications; | ||||||
6 | (9) identification of therapeutic duplication; | ||||||
7 | (10) patient laboratory values when authorized and | ||||||
8 | available; | ||||||
9 | (11) proper utilization (including over or under | ||||||
10 | utilization) and optimum therapeutic outcomes; and | ||||||
11 | (12) drug abuse and misuse. | ||||||
12 | "Medication therapy management services" includes the | ||||||
13 | following: | ||||||
14 | (1) documenting the services delivered and | ||||||
15 | communicating the information provided to patients' | ||||||
16 | prescribers within an appropriate time frame, not to | ||||||
17 | exceed 48 hours; | ||||||
18 | (2) providing patient counseling designed to enhance a | ||||||
19 | patient's understanding and the appropriate use of his or | ||||||
20 | her medications; and | ||||||
21 | (3) providing information, support services, and | ||||||
22 | resources designed to enhance a patient's adherence with | ||||||
23 | his or her prescribed therapeutic regimens. | ||||||
24 | "Medication therapy management services" may also include | ||||||
25 | patient care functions authorized by a physician licensed to | ||||||
26 | practice medicine in all its branches for his or her |
| |||||||
| |||||||
1 | identified patient or groups of patients under specified | ||||||
2 | conditions or limitations in a standing order from the | ||||||
3 | physician. | ||||||
4 | "Medication therapy management services" in a licensed | ||||||
5 | hospital may also include the following: | ||||||
6 | (1) reviewing assessments of the patient's health | ||||||
7 | status; and | ||||||
8 | (2) following protocols of a hospital pharmacy and | ||||||
9 | therapeutics committee with respect to the fulfillment of | ||||||
10 | medication orders. | ||||||
11 | (bb) "Pharmacist care" means the provision by a pharmacist | ||||||
12 | of medication therapy management services, with or without the | ||||||
13 | dispensing of drugs or devices, intended to achieve outcomes | ||||||
14 | that improve patient health, quality of life, and comfort and | ||||||
15 | enhance patient safety. | ||||||
16 | (cc) "Protected health information" means individually | ||||||
17 | identifiable health information that, except as otherwise | ||||||
18 | provided, is: | ||||||
19 | (1) transmitted by electronic media; | ||||||
20 | (2) maintained in any medium set forth in the | ||||||
21 | definition of "electronic media" in the federal Health | ||||||
22 | Insurance Portability and Accountability Act; or | ||||||
23 | (3) transmitted or maintained in any other form or | ||||||
24 | medium. | ||||||
25 | "Protected health information" does not include | ||||||
26 | individually identifiable health information found in: |
| |||||||
| |||||||
1 | (1) education records covered by the federal Family | ||||||
2 | Educational Right and Privacy Act; or | ||||||
3 | (2) employment records held by a licensee in its role | ||||||
4 | as an employer. | ||||||
5 | (dd) "Standing order" means a specific order for a patient | ||||||
6 | or group of patients issued by a physician licensed to | ||||||
7 | practice medicine in all its branches in Illinois. | ||||||
8 | (ee) "Address of record" means the designated address | ||||||
9 | recorded by the Department in the applicant's application file | ||||||
10 | or licensee's license file maintained by the Department's | ||||||
11 | licensure maintenance unit. | ||||||
12 | (ff) "Home pharmacy" means the location of a pharmacy's | ||||||
13 | primary operations. | ||||||
14 | (gg) "Email address of record" means the designated email | ||||||
15 | address recorded by the Department in the applicant's | ||||||
16 | application file or the licensee's license file, as maintained | ||||||
17 | by the Department's licensure maintenance unit. | ||||||
18 | (Source: P.A. 102-16, eff. 6-17-21; 102-103, eff. 1-1-22; | ||||||
19 | 102-558, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1051, eff. | ||||||
20 | 1-1-23; 103-1, eff. 4-27-23.) |